These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37951057)

  • 1. New tools can propel research in lysosomal storage diseases.
    Hertz E; Glasstetter LM; Chen Y; Sidransky E
    Mol Genet Metab; 2023 Dec; 140(4):107729. PubMed ID: 37951057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of induced pluripotent stem cells in lysosomal storage diseases.
    Kido J; Nakamura K; Era T
    Mol Cell Neurosci; 2020 Oct; 108():103540. PubMed ID: 32828964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal storage diseases: current therapies and future alternatives.
    Leal AF; Espejo-Mojica AJ; Sánchez OF; Ramírez CM; Reyes LH; Cruz JC; Alméciga-Díaz CJ
    J Mol Med (Berl); 2020 Jul; 98(7):931-946. PubMed ID: 32529345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineating the Neuropathology of Lysosomal Storage Diseases Using Patient-Derived Induced Pluripotent Stem Cells.
    Sabitha KR; Chandran D; Shetty AK; Upadhya D
    Stem Cells Dev; 2022 May; 31(9-10):221-238. PubMed ID: 35316126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction.
    Platt FM; Boland B; van der Spoel AC
    J Cell Biol; 2012 Nov; 199(5):723-34. PubMed ID: 23185029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal storage disorders - challenges, concepts and avenues for therapy: beyond rare diseases.
    Marques ARA; Saftig P
    J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30651381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cell models of lysosomal storage disorders.
    Borger DK; McMahon B; Roshan Lal T; Serra-Vinardell J; Aflaki E; Sidransky E
    Dis Model Mech; 2017 Jun; 10(6):691-704. PubMed ID: 28592657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phenotypic compound screening assay for lysosomal storage diseases.
    Xu M; Liu K; Swaroop M; Sun W; Dehdashti SJ; McKew JC; Zheng W
    J Biomol Screen; 2014 Jan; 19(1):168-75. PubMed ID: 23983233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome Editing Tools for Lysosomal Storage Disorders.
    Gonzalez EA; Nader H; Siebert M; Suarez DA; Alméciga-Díaz CJ; Baldo G
    Adv Exp Med Biol; 2023; 1429():127-155. PubMed ID: 37486520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease models for the development of therapies for lysosomal storage diseases.
    Xu M; Motabar O; Ferrer M; Marugan JJ; Zheng W; Ottinger EA
    Ann N Y Acad Sci; 2016 May; 1371(1):15-29. PubMed ID: 27144735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New strategies for the treatment of lysosomal storage diseases (review).
    Parenti G; Pignata C; Vajro P; Salerno M
    Int J Mol Med; 2013 Jan; 31(1):11-20. PubMed ID: 23165354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson's Disease.
    Blumenreich S; Barav OB; Jenkins BJ; Futerman AH
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32674335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving therapies in neuronopathic LSDs: opportunities and challenges.
    Rajan DS; Escolar ML
    Metab Brain Dis; 2022 Oct; 37(7):2245-2256. PubMed ID: 35442005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in therapies for neurological lysosomal storage disorders.
    Ellison S; Parker H; Bigger B
    J Inherit Metab Dis; 2023 Sep; 46(5):874-905. PubMed ID: 37078180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis of lysosomal storage diseases and their treatment.
    Winchester B; Vellodi A; Young E
    Biochem Soc Trans; 2000 Feb; 28(2):150-4. PubMed ID: 10816117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches.
    Moro E
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34208892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-Mediated Gene Editing in Human iPSC-Derived Macrophage Reveals Lysosomal Acid Lipase Function in Human Macrophages-Brief Report.
    Zhang H; Shi J; Hachet MA; Xue C; Bauer RC; Jiang H; Li W; Tohyama J; Millar J; Billheimer J; Phillips MC; Razani B; Rader DJ; Reilly MP
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2156-2160. PubMed ID: 28882870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyso-IP: Uncovering Pathogenic Mechanisms of Lysosomal Dysfunction.
    Chen C; Sidransky E; Chen Y
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipid lysosomal storage disorders.
    Platt FM
    Nature; 2014 Jun; 510(7503):68-75. PubMed ID: 24899306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Lysosomal Storage Disorders to Parkinson's Disease - Challenges and Opportunities.
    Mächtel R; Boros FA; Dobert JP; Arnold P; Zunke F
    J Mol Biol; 2023 Jun; 435(12):167932. PubMed ID: 36572237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.